1. Home
  2. |Insights
  3. |The Orange County (CA) Regulatory Affairs Annual Educational Conference

The Orange County (CA) Regulatory Affairs Annual Educational Conference

Event | 06.17.10, 12:00 AM UTC - 12:00 AM UTC

The theme of this conference is “Regulatory Affairs: The Business of Regulatory Affairs.”

The conference is intended to provide the Drug, Device, and Biologics industries with an opportunity to interact with FDA reviewers and compliance officers from the Centers and District Offices, as well as other industry experts. The main focus of this interactive conference will be product approval, compliance, and risk management in the three medical product areas. Industry speakers, interactive Q & A, and workshop sessions will also be included to assure open exchange and dialogue on the relevant regulatory issues.

Steve Niedelman is speaking at this conference. The topic is "Enforcement Activities of Significance: Consent Decrees 2009 (KV Pharmaceuticals, Caraco, and CareTech) and Stories from the trenches."

For more information, please visit these areas: Product Risk Management

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.